Thymosin alpha 1 therapy alleviates organ dysfunction of sepsis patients: a retrospective cohort study

Aim: Thymosin alpha 1 (Tα1) is a promising treatment for the improvement of sepsis patients. Until now, its function in reducing acute organ damage of sepsis patients is still unclear. The aim of this study was to determine whether Tα1 can alleviate organ dysfunction in sepsis patients. Methods: Th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fei Pei, Yishan Liu, Lingyun Zuo, Bin Gu, Liqun Liang, Luhao Wang, Yao Nie, Minying Chen, Xiangdong Guan, Jianfeng Wu, on behalf of the China Critical Care Immunotherapy Research Group
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Open Exploration Publishing Inc. 2022-04-01
Saila:Exploration of Immunology
Gaiak:
immunoparalysis
immunotherapy
thymosin alpha 1
sepsis
sequential organ failure assessment score
Sarrera elektronikoa:https://www.explorationpub.com/Journals/ei/Article/100345
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak